The Asia Pacific market is the fastest growing market for anticoccidials. This is primarily due to the increased demand for meat proteins in countries like China, India, Malaysia etc. The increased demand for meat proteins has increased the meat production in the region. China is the leading contributor in this region. The region is characterized by a myriad of small players in the market both for Meat production as well as antimicrobial agent production. This is leading to a price war as these cheap alternatives are giving the multinationals a run for their money. The Asia pacific market for anticoccidials has grown at a CAGR of 8.4% from 2016 to 2021 and the growth is expected to continue during the forecasted period. Currently very little regulations are in place leaving the market unorganized and open for competition to enter.
The Market research report titled Asia - Pacific Anticoccidial Drugs Market In Animal Health - Trends And Forecasts - (2016-21) by MORDOR INTELLIGENCE categorizes the global anticoccidial market on the basis of Animal Types (Poultry, Cattle, Swine, and companion animals), by Drugs (Ionophore anticoccidials, Chemical derivative anticoccidials and Antibiotic anticoccidials) and by Geography (China, India, Japan & Australia).
Key players in the Anticoccidial Drugs Market are Zoetis, Elanco (A division of Eli Lilly and Company), Merial, Bayer Health care Animal Healthcare division, Merck Animal Healthcare, Boehringer Ingelheim Animal Health, Virbac, and Novartis Animal Healthcare.
What the report offers: